BREAKING
Super League Enterprise, Inc. (SLE) Reports Q4 Earnings 4 minutes ago Arcadia Biosciences 2025 Financial Results 23 minutes ago Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Earnings 27 minutes ago X Financial (XYF) Q4 2025 Earnings Recap 32 minutes ago SBC Medical Group Holdings Incorporated (SBC) Beats Q4 EPS Estimates by 16.7% 49 minutes ago Vivani Medical 2025 Financial Results Analysis 51 minutes ago Huize Holding Limited (HUIZ) Reports Q4 Earnings 53 minutes ago Oxford Industries Fiscal 2025 Financial Review 1 hour ago Southland Holdings, Inc. (SLND) Reports Wider Q4 Loss Than Expected 1 hour ago CapsoVision 2025 Financial Performance Review 1 hour ago Super League Enterprise, Inc. (SLE) Reports Q4 Earnings 4 minutes ago Arcadia Biosciences 2025 Financial Results 23 minutes ago Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Earnings 27 minutes ago X Financial (XYF) Q4 2025 Earnings Recap 32 minutes ago SBC Medical Group Holdings Incorporated (SBC) Beats Q4 EPS Estimates by 16.7% 49 minutes ago Vivani Medical 2025 Financial Results Analysis 51 minutes ago Huize Holding Limited (HUIZ) Reports Q4 Earnings 53 minutes ago Oxford Industries Fiscal 2025 Financial Review 1 hour ago Southland Holdings, Inc. (SLND) Reports Wider Q4 Loss Than Expected 1 hour ago CapsoVision 2025 Financial Performance Review 1 hour ago
ADVERTISEMENT
AlphaGraphs

Walgreens Boots Alliance (WBA) Q2 2025 Earnings: Key financials and quarterly highlights

Walgreens Boots Alliance (NASDAQ: WBA) reported its second quarter 2025 earnings results today. Sales increased 4.1% year-over-year to $38.6 billion. Sales growth was 4.7% on a constant currency basis. The top line reflects sales growth in the US Retail Pharmacy and International segments. Net loss was $2.9 billion, or $3.30 per share, compared to a […]

April 8, 2025 1 min read

Walgreens Boots Alliance (NASDAQ: WBA) reported its second quarter 2025 earnings results today. Sales increased 4.1% year-over-year to $38.6 billion. Sales growth was 4.7% on a constant currency basis. The top line reflects sales growth in the US Retail Pharmacy and International segments. Net loss was $2.9 billion, or $3.30 per share, compared to a […]

Walgreens Boots Alliance (NASDAQ: WBA) reported its second quarter 2025 earnings results today.

Sales increased 4.1% year-over-year to $38.6 billion. Sales growth was 4.7% on a constant currency basis. The top line reflects sales growth in the US Retail Pharmacy and International segments.

Net loss was $2.9 billion, or $3.30 per share, compared to a loss of $5.9 billion, or $6.85 per share, last year. Adjusted EPS was $0.63, down 47.3% on a constant currency basis.

On March 6, 2025, WBA entered into a definitive agreement to be acquired by Sycamore Partners. The merger is expected to close in the fourth quarter of calendar year 2025. As a result, the company is not providing guidance for fiscal year 2025.

Prior performance

Walgreens Boots Alliance Q1 2025 earnings infographic
ADVERTISEMENT